A popular class of weight loss drugs may offer more lasting success than assumed, new data from Epic Research suggests. The study of medical records found that a slight majority of people who took GLP-1 drugs like semaglutide either maintained or improved their weight loss in the year after they stopped using the medication. More … Read more
The slim version A year ago, most people had never heard the word “Ozempic.” Now, the weight loss “wonder drug” and a nearly identical prescription called Wegovy are on the tip of everyone’s tongues. The weekly injectable, initially developed to treat Type 1 diabetes, has been hailed as a “breakthrough,” a “game-changer,” “revolutionary,” and, yes, … Read more
In a recent study published in the journal eClinical Medicine, researchers performed a meta-analysis to evaluate the glucose-lowering potential of glucagon-like peptide-1 receptor agonist (GLP-1 RA)-based therapies among diabetes mellitus type 2 (T2D) patients. Novel GLP-1-RAs, including tirzepatide, individually or combined with insulin fixed-ratio combinations (FRCs) or sodium-glucose cotransporter-2 inhibitors (SGLT-2i), as well as high-dosage … Read more